SA
IHI icon

Strategic Advocates’s iShares US Medical Devices ETF IHI Stock Holding History

Strategic Advocates’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,580
Closed -$212K – 118
2024
Q3 		$212K Hold
3,580
– – 0.08% 112
2024
Q2 		$201K Hold
3,580
– – 0.08% 116
2024
Q1 		$210K Buy
+3,580
New +$202K 0.08% 119

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Strategic Advocates's IHI Position: Q4 2024 in Review

Strategic Advocates sold out of iShares US Medical Devices ETF (IHI) in Q4 2024, closing a stake of 3,580 shares — an estimated $212K sold.

Strategic Advocates first reported a position in IHI in Q1 2024 and held it in 3 quarters. The position peaked at $212K in Q3 2024. 566 funds tracked by Wall St. Rank hold IHI as of Q4 2024.

  • Strategic Advocates reported no remaining iShares US Medical Devices ETF position as of Q4 2024 after selling out during the quarter.
  • Strategic Advocates sold 3,580 iShares US Medical Devices ETF shares in Q4 2024, an estimated $212K.
  • Strategic Advocates first reported a position in iShares US Medical Devices ETF in Q1 2024 and held it in 3 quarters.
  • Strategic Advocates's iShares US Medical Devices ETF position peaked at $212K in Q3 2024.
  • 566 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2024.

Based on Strategic Advocates's 13F filing for Q4 2024, filed 23 Jan 2025.